Hemoglobin Genotypes Modulate Inflammatory Response to Plasmodium Infection.

Show simple item record

dc.contributor.author Harp, K. O.
dc.contributor.author Botchway, F.
dc.contributor.author Dei-Adomakoh, Y.
dc.contributor.author Wilson, M. D.
dc.contributor.author Hood, J. L.
dc.contributor.author Adjei, A. A.
dc.contributor.author Driss, A.
dc.date.accessioned 2022-09-02T11:33:23Z
dc.date.available 2022-09-02T11:33:23Z
dc.date.issued 2020
dc.identifier.other 10.3389/fimmu.2020.593546
dc.identifier.uri https://pubmed.ncbi.nlm.nih.gov/33424841/
dc.identifier.uri http://atuspace.atu.edu.gh:8080/handle/123456789/194
dc.description.abstract In 2018, 228 million cases and 405,000 malaria-associated deaths were reported worldwide with a majority being in Africa. A wide range of factors, including parasitemia, host immunity, inflammatory responses to infection, and host hemoglobin genotype, mediate the severity of malaria. Among the hemoglobinopathies, hemoglobin S (HbS) is caused by a single amino acid substitution of Glutamic Acid replaced by Valine at the sixth position of the beta-globin chain (E6V). Hemoglobin C (HbC) on the other hand, involves a single amino acid substitution of Glutamic Acid by a Lysine (E6K), which has received the most attention. These substitutions alter the stability of Hb leading to wide-ranging hematological disorders. The homozygous state of hemoglobin S (HbSS) results in sickle cell anemia (SCA) whereas the heterozygous state (HbAS) results in sickle cell trait (SCT). Both mutations are reported to mediate the reduction in the severity and fatality of Plasmodium falciparum malaria. The mechanism underlying this protection is poorly understood. Since both malaria and sickle cell disease (SCD) are associated with the destruction of erythrocytes and widespread systemic inflammation, identifying which inflammatory factor(s) mediate susceptibility of individuals with different hemoglobin genotypes to Plasmodium infection could result in the discovery of new predictive markers and interventions against malaria or SCD severity. We hypothesized that hemoglobin genotypes modulate the inflammatory response to Plasmodium infection. We conducted a cross-sectional study in Ghana, West Africa, between 2014 and 2019 to ascertain the relationships between blood inflammatory cytokines, Plasmodium infection, and hemoglobin genotype. A total of 923 volunteers were enrolled in the study. A total of 74, age and sex-matched subjects were identified with various genotypes including HbAS, HbAC, HbSS, HbSC, HbCC, or HbAA. Complete blood counts and serum inflammatory cytokine expression levels were assessed. The results indicate that differential expression of CXCL10, TNF-α, CCL2, IL-8, and IL-6 were tightly linked to hemoglobin genotype and severity of Plasmodium infection and that these cytokine levels may be predictive for susceptibility to severe malaria or SCD severity. en_US
dc.language.iso en en_US
dc.publisher PMC en_US
dc.relation.ispartofseries vol;11
dc.subject Hemoglobin C en_US
dc.subject Biomarkers en_US
dc.subject Cerebral malaria en_US
dc.subject Chemokines en_US
dc.subject Cytokines en_US
dc.subject Malaria severity en_US
dc.subject Sickle cell disease en_US
dc.subject Sickle cell trait en_US
dc.title Hemoglobin Genotypes Modulate Inflammatory Response to Plasmodium Infection. en_US
dc.type Article en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Advanced Search

Browse

My Account